The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Morana Jaganjac et al, 2020, Antioxidants CrossRef
TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
Binsheng Fu et al, 2017, BioMed Research International CrossRef
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
Prahlad V. Raninga et al, 2015, Oncotarget CrossRef
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
Erin Clapper et al, 2020, Antioxidants CrossRef
Acetylated Thioredoxin Reductase 1 Resists Oxidative Inactivation
David. E. Wright et al, 2021, Frontiers in Chemistry CrossRef
Thioredoxin 1 is required for stress granule assembly upon arsenite-induced oxidative stress
Bogdan Jovanovic et al, 2021, Food and Chemical Toxicology CrossRef
Auranofin is a potent suppressor of osteosarcoma metastasis
Eleni Topkas et al, 2016, Oncotarget CrossRef
ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
Gan Huang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
Why Nature Chose Selenium
Hans J. Reich et al, 2016, ACS Chemical Biology CrossRef
The role of thioredoxin system in cancer: strategy for cancer therapy
Jin-Jing Jia et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
Mitocans: Mitochondrially Targeted Anti-cancer Drugs
Stepana Boukalova et al, 2018, Mitochondrial Biology and Experimental Therapeutics CrossRef
Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC
Manaswita Saikia et al, 2022, SN Computer Science CrossRef
Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels
Xia Ying Cui et al, 2022, Molecules CrossRef
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
Hui Wang et al, 2017, Oncotarget CrossRef